Epidemiology of diabetes and diabetic complications in China
- PMID: 29392352
- DOI: 10.1007/s00125-018-4557-7
Epidemiology of diabetes and diabetic complications in China
Erratum in
-
Correction to: Epidemiology of diabetes and diabetic complications in China.Diabetologia. 2018 Jun;61(6):1491. doi: 10.1007/s00125-018-4616-0. Diabetologia. 2018. PMID: 29700561
Abstract
The People's Republic of China (herein referred to as China) has witnessed one of the most dramatic rises in diabetes prevalence anywhere in the world. The latest epidemiological study suggests that approximately 11% of the population has diabetes, with a significant proportion remaining undiagnosed. Risk factors for diabetes in the Chinese population are similar to those in other populations, though gestational diabetes and young-onset diabetes is becoming increasingly common. Data on the prevalence of diabetic complications remain limited, though cardio-renal complications account for significant morbidity and mortality. Other diabetes-related comorbidities are becoming increasingly common, with cancer emerging as a major cause of mortality among individuals with diabetes. There are many challenges and obstacles that impede effective diabetes prevention and the delivery of care, though much progress has occurred over recent years. Lessons learnt from how China has responded to the challenges posed by the diabetes epidemic will be invaluable for other countries facing the many threats of diabetes and its complications.
Keywords: China; Coronary heart disease; Diabetes; Diabetic kidney disease; Epidemiology; Genetics; Gestational diabetes; Obesity; Review; Risk factors.
Similar articles
-
Diabetes in sub-Saharan Africa.Lancet. 2010 Jun 26;375(9733):2254-66. doi: 10.1016/S0140-6736(10)60550-8. Lancet. 2010. PMID: 20609971 Review.
-
[Epidemiology of diabetes in the elderly].Rev Invest Clin. 2010 Jul-Aug;62(4):305-11. Rev Invest Clin. 2010. PMID: 21222308 Review. Spanish.
-
Diabetes mellitus and its complications in India.Nat Rev Endocrinol. 2016 Jun;12(6):357-70. doi: 10.1038/nrendo.2016.53. Epub 2016 Apr 15. Nat Rev Endocrinol. 2016. PMID: 27080137 Review.
-
Diabetes mellitus epidemiology-classification, determinants, and public health impacts.J Miss State Med Assoc. 2004 Dec;45(12):355-62. J Miss State Med Assoc. 2004. PMID: 15638167 Review.
-
Epidemiology, complications and management of diabetes in Ethiopia: a systematic review.J Diabetes. 2012 Jun;4(2):174-80. doi: 10.1111/j.1753-0407.2011.00181.x. J Diabetes. 2012. PMID: 22212307 Review.
Cited by
-
Effect of oxymatrine on liver gluconeogenesis is associated with the regulation of PEPCK and G6Pase expression and AKT phosphorylation.Biomed Rep. 2021 Jul;15(1):56. doi: 10.3892/br.2021.1432. Epub 2021 Apr 27. Biomed Rep. 2021. PMID: 34007449 Free PMC article.
-
Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review.Front Endocrinol (Lausanne). 2022 Mar 7;13:836365. doi: 10.3389/fendo.2022.836365. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35330915 Free PMC article.
-
ARIMA model for predicting chronic kidney disease and estimating its economic burden in China.BMC Public Health. 2022 Dec 30;22(1):2456. doi: 10.1186/s12889-022-14959-z. BMC Public Health. 2022. PMID: 36585665 Free PMC article.
-
MMC celebrating 6 years of experience and expansion.J Diabetes. 2022 May;14(5):356-357. doi: 10.1111/1753-0407.13270. Epub 2022 May 11. J Diabetes. 2022. PMID: 35545818 Free PMC article. No abstract available.
-
Renoprotective effect of JinQi-JiangTang tablet on high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats.RSC Adv. 2018 Dec 14;8(73):41858-41871. doi: 10.1039/c8ra07858k. eCollection 2018 Dec 12. RSC Adv. 2018. PMID: 35558809 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical